drugset / Trial / NCT02513589

Molecular Imaging of Inflammation With 18F-PBR06 to Identify Unstable Carotid Plaques in Patients With Stroke

NCT02513589

Phase 2 Terminated 3 enrolled University Hospital, Bordeaux
NaSingle-groupOpen-labelDiagnostic

Summary

Evaluating an innovative molecular imaging technique to visualize inflammation of the atherosclerotic plaque in patients with a recent ischemic stroke (\<15 days) with carotid stenosis\> 50%, by performing a Positron emission tomography-computed tomography (PET-CT) with PBR06 18F, a tracer for Translocator protein (TPSO).

Timeline

Start
2017-09-18
Primary completion
2018-07-04
Completion
2018-07-04

Drugs

EvaluationDrugModalityDoseRoute
Subject [F-18]PBR06 Diagnostic / imaging agent

Indications